In the version of this Letter originally published, the TUBA immunoblotting panel and the Coomassie-stained panel was used in Figure 5c (in the dataset corresponding to let-7 antagomir treatment, top set of panels), and reused in Figure 5e , without appropriate acknowledgement. The Coomassie-stained gel was vertically flipped in Figure 5e but the alignment of the lanes was maintained. The TUBA immunoblot and Coomassiestained membranes represent experimental controls. The p62 panel in Figures 2j and 2k (CQ-treated) was also reused without appropriate attribution. In all cases of reuse of blots between panels, the samples were obtained within one representative experiment and processed in parallel.
